✦ LIBER ✦

Patients’ access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries

✍ Scribed by Laires, P. A.; Exposto, F.; Mesquita, R.; Martins, A. P.; Cunha-Miranda, L.; Fonseca, J. E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS75 Explanatory Factors for the Rheuma

✍ P.A. Laires; F. Exposto; P. Barosa; B. Hormigos; A.P. Martins 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMS56 ACCESS TO BIOLOGIC TREATMENT IN RH

✍ E Orlewska; I Ancuta; B Anic; C Codreanu; N Damjanov; P Djukic; L Gulacsi; R Ion 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Efficacy and safety of infliximab-biosim

✍ Baji, Petra; Péntek, Márta; Czirják, László; Szekanecz, Zoltán; Nagy, György; Gu 📂 Article 📅 2014 🏛 Springer 🌐 French ⚖ 850 KB

Indirect Comparison of Tocilizumab and O

✍ Gert J.D. Bergman; Marc C. Hochberg; Maarten Boers; Neil Wintfeld; Adrian Kielho 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 595 KB

A Multi-Country Physician Survey On Pati

✍ Narayanan, S.; Lu, Y.; Hutchings, R.; Baskett, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PMS33 Cost-Efficacy Analysis of Biologic

✍ A. Cafe; I. Monteiro; J.F. Loff; R. Encarnação 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB